Related Experiment Videos
Anaerobic coverage for intra-amnionic infection: maternal and perinatal impact
M C Maberry1, L C Gilstrap, R Bawdon
1Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas 75235-9032.
American Journal of Perinatology
|September 1, 1991
Summary
Adding clindamycin to ampicillin and gentamicin for intra-amnionic infection did not significantly reduce endometritis rates in women undergoing cesarean delivery. Neonatal outcomes were also similar between dual and triple antibiotic therapy groups.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Pharmacology
Background:
- Intrapartum antibiotics are crucial for maternal and neonatal health.
- Optimal antibiotic regimens for intra-amnionic infection, particularly anaerobic coverage, remain debated.
Purpose of the Study:
- To compare the efficacy of dual-agent (ampicillin and gentamicin) versus triple-agent (ampicillin, gentamicin, and clindamycin) therapy for intra-amnionic infection.
- To assess the impact of anaerobic coverage on endometritis incidence and neonatal outcomes.
Main Methods:
- Randomized trial involving pregnant women diagnosed with intra-amnionic infection.
- Participants received either dual-agent or triple-agent antibiotic therapy.
- Outcomes included delivery mode, endometritis incidence, and neonatal morbidity/mortality.
Main Results:
- No significant difference in vaginal or cesarean delivery frequency between groups.
- Endometritis incidence was similar: 10 of 69 in the dual-therapy group vs. 5 of 64 in the triple-therapy group (p = NS).
- Neonatal morbidity and mortality rates showed no significant differences between the treatment arms.
Conclusions:
- Adding clindamycin for anaerobic coverage to ampicillin and gentamicin does not significantly reduce endometritis in women with intra-amnionic infection.
- The findings suggest current dual-agent therapy may be sufficient, though potential benefits in vaginally delivered patients warrant further investigation.